| XBRANE BIOPHARMA AB |
| Schweden |
| Gesundheit |
| SE0026598583 / A41PJJ |
| 7XB0 (Frankfurt) |
| FRA:7XB0, ETR:7XB0, 7XB0:GR |
| - |
| https://www.xbrane.com/ |
|
Xbrane Biopharma AB is a Sweden-based biotechnology company specializing in the development, manufacture, and commercialization of biosimilars. These follow-on biologics target high-cost originator drugs, aiming to provide affordable alternatives for..
>Volltext.. |
| 12.61 Mio. EUR |
| 10.01 Mio. EUR |
| 14.28 Mio. EUR |
| -1.55 Mio. EUR |
| 11.93 Mio. EUR |
| 1.24 EUR |
| 5.47 Mio. EUR |
| 8.12 Mio. EUR |
| -23.5 Mio. EUR |
| 1.64 |
| -18.76% |
| - |
| - |
| - |
| - |
| - |
| XBRANE |
| 05.04.26 |
|